Loading
The whole lifecycle, verified against the filings.
Rumor → LOI → definitive → approved
Summed over 12 of 14 filed.
More equity than the headline, over 10 of 14 measured.
A definitive agreement is signed and the vote is still ahead, so the redemption right survives to it.
The list is grouped by lifecycle stage and the sort orders rows inside a stage: a vote that has already passed and one still ahead are not the same list. An announced deal is not a closed deal — 1 of the combinations in our record were terminated. A premium to trust is a selling point, not a buying point — and once a vote has passed there is no redemption right left to price against. Every stage, target and figure here is read from the SEC filing that stated it; where a figure is missing it is missing from our record, and the page says so rather than estimating one.
7 of 14 deals in this view carry a dated vote or a stated close period. Where the Vote column is empty, the filings we hold state neither — that is a gap in our record, not a claim that the parties have no timetable.
Sorted inside each stage.
| NTWONewbury Street II Acquisition Corp | FORT Robotics, Inc. | AI/Tech | $500M | Aug 18, 2026 | Q4 2026 | $10.90 | -1.6% | Definitive (DA signed) | 7171 | FORT Robotics, Inc., founded in 2018 by Samuel Reeves and headquartered in Philadelphia, is a safety and security platform company that has branded itself "The Trust Layer for Physical AI." The platform serves as foundational safety infrastructure enabling autonomous machines from different manufacturers to operate safely alongside humans and within shared environments. FORT's technology is machine- and application-agnostic, combining three safety frameworks—human-in-the-loop control, inside-out safety, and outside-in safety—into a unified suite of hardware, software, and services. Its hardware portfolio includes wireless emergency stops, vehicle safety controllers, endpoint controllers, and safe remote controls, complemented by software for connectivity aggregation, remote operation, and fleet management. The platform is backed by 25 patents and certified to Safety Integrity Level 3 per IEC 61508, with worldwide regulatory certifications including FCC, CE Mark, and Giteki Mark. FORT serves more than 600 customers globally across industries including humanoid robotics, warehousing, transportation, manufacturing, construction, agriculture, mining, energy, and defense, with notable clients such as Agility Robotics, Google DeepMind, Cobot, Zoox, DoorDash, Textron, Ocado, Oxa, and Carnegie Robotics. The company grew out of Reeves's previous venture, Humanistic Robotics, which built robots for landmine clearance—a decade of work that revealed the absence of safety infrastructure for autonomous machines operating in real-world environments. FORT has raised approximately $57 million across three funding rounds, most recently a $19 million Series B in August 2025 led by Tiger Global Management, with earlier rounds including a $13 million Series A in March 2021 and a $25 million Series B in July 2022. Backers include Tiger Global, Mark Cuban Companies, Prologis Ventures, Five Eleven Partners, Prime Movers Lab, Highland Capital Partners, and Lemnos Labs, among others. The company demonstrated strong commercial momentum heading into its public listing, with 2025 revenue growing 62 percent year-over-year—including 91 percent growth among customers spending more than $100,000 annually—while operating expenses grew only 19 percent. FORT reported standalone gross margins of 70 percent in 2024 and 66 percent in 2025, revenue per employee of $276,000, and no single customer representing more than 9 percent of 2025 revenue. The company has deployed more than 19,500 units globally and has grown its six-figure customer base by 3.8 times since 2021. FORT's leadership team includes founder and CEO Samuel Reeves, founding CTO Nathan Bivans—who sits on the U.S. Technical Advisory Group to ISO TC 200 for safety standards development—head of productmore ▾less ▴ |
| NBRGNewbridge Acquisition | Startech Group | AI/Tech | $1.0B | Aug 4, 2026 | $10.06 | -8.3% | Definitive (DA signed) | 5959 | Startech Group Inc. is a U.S.-based Delaware corporation operating at the intersection of artificial intelligence, fintech, and life sciences technology. The company is structured around two complementary business segments: aquaporin functional water (AQP Water) and the StarOS platform, an agent operating system designed for the AI era. The AQP Water segment focuses on functional-water products and is expected to generate contractual per-bottle technology and settlement service revenue tied to product sales and digital product management. The StarOS segment represents Startech's AI platform business, intended to generate revenue from AI-enabled software and platform services. Together, these segments aim to blend consumer-product-related revenue opportunities with potentially scalable AI software and platform-based revenue streams, all oriented toward enhancing human health and longevity through AI-powered healthcare technologies. Startech is going public via a definitive business combination agreement with Newbridge Acquisition Limited (Nasdaq: NBRGU), a blank-check company that raised $57.5 million in its January 2026 IPO. The all-stock transaction values Startech at approximately $1.0 billion, with Startech's stockholders and management set to receive 100,000,000 common shares of the combined entity. The deal has been unanimously approved by the boards of both companies, and Newbridge has secured support agreements from its sponsor, Wealth Path Holdings, as well as from certain Startech shareholders, committing them to vote in favor of the transaction and against alternatives. Prior to closing, Newbridge plans to re-domicile from the British Virgin Islands to Delaware, after which Newbridge Merger Sub will merge into Startech, making Startech a wholly owned subsidiary. The combined company plans to remain Nasdaq-listed under a new ticker symbol, with certain Startech shareholders subject to a six-month lock-up period following closing. The rationale for the SPAC merger is to take Startech's AI platform public and scale its growth, leveraging the public markets to accelerate development of its dual business lines. The transaction remains subject to customary closing conditions, including shareholder approvals from both companies, SEC effectiveness of a Form S-4 registration statement, and Nasdaq approval of the combined company's listing application. Legal counsel for Newbridge includes Loeb & Loeb LLP and Forbes Hare, while Torres & Zheng Law, P.C. serves as legal counsel to Startech. The deal was announced on August 3, 2026, and positions Startech to capitalize on the convergence of consumer health products and AI-driven platform services in the public markets.more ▾less ▴ |
| ALISCalisa Acquisition Corp | Goodvision AI Inc. | AI/Tech | — | Aug 4, 2026 | $10.28 | -0.3% | Definitive (DA signed) | 6969 |
| BLRKBluerock | Yellow.ai | AI/Tech | $300M | Aug 3, 2026 | H2 2026 | $10.11 | +0.8% | Definitive (DA signed) | 7171 | Yellow.ai, formerly Yellow Messenger, is an enterprise agentic AI platform company specializing in service automation for large organizations. Founded in 2016 in Bangalore, India by Raghu Ravinutala, Jaya Kishore Reddy Gollareddy, and Rashid Khan, the company is now headquartered in San Mateo, California, and operates as a subsidiary of Bitonic Technology Labs Pvt. Ltd. Its core platform, called Nexus, uses a multi-LLM architecture that dynamically orchestrates more than fifteen models — including those from OpenAI, Anthropic, and proprietary sources — to deploy autonomous AI agents capable of planning tasks, acting on them, and resolving issues across voice, chat, email, and social channels. The platform supports over 135 languages across 85-plus countries, integrates with more than 100 enterprise systems, and handles approximately 16 billion conversations annually for over 650 enterprise clients. Its fastest-growing and most widely adopted product is Nexus Vox, a low-latency voice agent delivering human-like conversations in contact centers. Enterprise accounts now constitute over 70 percent of recurring revenue, reflecting a deliberate strategic shift toward large, durable contracts. The company has been recognized as a Strong Performer in The Forrester Wave for Conversational AI Platforms (Q2 2026) and was named a Challenger in Gartner's Magic Quadrant for Enterprise Conversational AI Platforms in 2023 and 2025. The company has raised over $102 million across three funding rounds from blue-chip investors including Lightspeed Venture Partners, Salesforce Ventures, Sapphire Ventures, and WestBridge Capital. Its Series A brought in $4 million in 2019, followed by a $20 million Series B in 2020 and a $78.15 million Series C in 2021. Revenue has grown steadily, from $11.6 million in fiscal year 2022 to $34.8 million in fiscal year 2026 (ending January 31, 2026), with management projecting $37.3 million and its first EBITDA-positive year in fiscal 2027. The founding leadership team has expanded from three to five partners: Ravinutala serves as CEO, Reddy as Chief Product Officer, Khan as CMO and Head of Investor Relations, while Kaushik Bhaskar was brought in for business process outsourcing operating leadership and Nand Sharma for private-equity roll-up execution — additions specifically designed to support the company's consolidation strategy. Yellow.ai is going public via a definitive Business Combination Agreement with Bluerock Acquisition Corp. (Nasdaq: BLRK), a special purpose acquisition company, at a pro forma equity value of approximately $550 million and a pre-money valuation of roughly $300 million. The transaction is expected to generate over $200 million in gross proceeds, including approximately $175 million from Bluerock's trust account assuming no redemptions and $30 million in committed PIPE financing from institutional investors. The deal structure also includes up to $50 million in senior secured convertible notes bearing 12 percent interest. Notably, the founders and key management are investing their own capital in the PIPE alongside institutional investors, signaling long-term alignment. The combined company will trade on Nasdaq under the ticker "YAI," with a nine-member board — eight directors designated |
| APXTApex Treasury | TECfusions, Inc. | AI/Tech | $4.0B | Jul 22, 2026 | Q4 2026 | $10.14 | +1.0% | Definitive (DA signed) | 7171 | TECfusions, Inc. is a digital infrastructure company founded in 2023 that specializes in the design, construction, and operation of AI-ready data centers and power infrastructure. Operating at the intersection of technology, environment, and community, the company employs a vertically integrated approach to develop high-density data centers tailored for artificial intelligence and high-performance computing workloads. TECfusions is led by founder and CTO Simon Tusha, a former CTO of QTS, who has steered the company’s strategy of adapting and reusing legacy industrial sites to accelerate deployment in power-constrained markets. By focusing on providing space, power, and efficient low-water cooling to tenants, TECfusions avoids direct exposure to the more volatile GPU ownership and compute layers, instead positioning itself as an infrastructure provider for hyperscalers, neocloud tenants, and enterprise AI customers. The company’s current portfolio reflects a mix of live, contracted, and planned capacity across strategic U.S. markets, anchored by a stated multi-gigawatt development pipeline. In Clarksville, Virginia, TECfusions operates 37 megawatts of fully leased live capacity with potential for a 220-megawatt expansion. Its Tucson, Arizona site features 16 megawatts live and 12 megawatts contracted, alongside plans for an additional 20 megawatts. The company's most ambitious project is the TECfusions Keystone Connect campus in New Kensington, Pennsylvania, where it acquired 1,395 acres of a former Alcoa R&D facility. This site currently has 2 megawatts live and 12 megawatts contracted, but is designed for a massive 3-gigawatt build-out over six years, supported by on-site natural gas power generation and a $2 million state redevelopment grant. Among its customers, TECfusions counts neocloud provider TensorWave, which has split 20 megawattsmore ▾less ▴ |
| QETAQuetta Acquisition CorpNo date ahead | Smart Kreate Group Limited | AI/Tech | — | Jul 8, 2026 | $11.85 | -1.3% | Definitive (DA signed) | 6868 |
| CCXIChurchill Capital XI | Agility Robotics, Inc. | AI/Tech | $2.5B | Jun 24, 2026 | 2026 | $12.81 | -26.0% | Definitive (DA signed) | 33Premium risk33Premium risk | Agility Robotics, Inc., which rebranded simply as "Agility" in March 2026, is a Salem, Oregon-based humanoid robotics and physical AI company founded in 2015 as a spin-off from Oregon State University's Dynamic Robotics Laboratory by Dr. Jonathan Hurst, Dr. Damion Shelton, and Mikhail Jones. The company develops bipedal humanoid robots designed to work alongside humans in manufacturing, distribution, and logistics environments, addressing chronic physical labor shortages by automating repetitive and physically demanding tasks. Its flagship product is Digit, a general-purpose humanoid robot standing roughly five-foot-nine and weighing 160 pounds, featuring reverse-bend knees for human-like mobility. The current generation, Digit v4, can carry 35 pounds and operate for 16 hours on a charge, while the forthcoming Digit v5—designed to be the world's first cooperatively safe humanoid—will lift up to 50 pounds, run for approximately 22 hours, and reach up to 7.2 feet. Agility also offers Agility Arc, a cloud-based automation platform for fleet orchestration and integration with warehouse management systems. The company employs approximately 452 people and operates additional facilities in Pittsburgh and Fremont, California. CEO Peggy Johnson, who previously led Magic Leap and spent six years as Executive Vice President of Business Development at Microsoft following a 24-year career at Qualcomm, guides the company's commercial growth alongside a leadership team that includes co-founder and Chief Robot Officer Jonathan Hurst, Chief Business Officer Daniel Diez, CTO Pras Velagapudi, and COO/CFO Jennifer Hunter. Agility has raised approximately $683 million in total funding from a roster of strategic investors spanning the AI, technology, venture capital, and industrial ecosystems, including DCVC, NVIDIA, Amazon, SoftBank Vision Fund 2, Foxconn, Schaeffler, Abico, and Playground Global. The company has built out its manufacturing infrastructure at RoboFab, a 70,000-square-foot modular facility in Salem designed to support production of up to 10,000 units annually, with roughly 75% of Digit's components sourced within the United States. Agility holds 74 patents and has accumulated over 65,000 hours of real-world robot operation across nine customer facilities, generating a proprietary data flywheel that continuously improves its embodied AI systems. Agility's commercial traction is anchored by active deployments with major enterprises including Schaeffler, GXO Logistics, Toyota Motor Manufacturing Canada, Amazon, and Mercado Libre, where Digit automates tasks such as machine tending, tote handling, and sortation. The company secured the industry's first humanoid Robot-as-a-Service contract with GXO and has booked more than $300 million in multi-year contracted orders for Digit v5, representing roughly 1,000 robots, with a growing pipeline of over 30 customers. Management estimates the addressable U.S. market opportunity across manufacturing, distribution, and logistics at approximately $1 trillion. The company also runs a Customer Acceleration Program to help enterprises evaluate and prepare for large-scale humanoid adoption, feeding a pipeline of future deployments across industries. On June 24, 2026, Agility announced a definitive business combination agreement with Churchill Capital Corp XI (NASDAQ: CCXI), a special purpose acquisition company led by Michael Klein, in a transaction valuing Agility at approximately $2.5 billion pre-money and expected to raise over $620 million in gross proceeds, including roughly $200 million in PIPE financing committed at $10 per share by leading institutional investors. The merger is intended to create the first U.S.-listed pure-play humanoid robotics equity, with the combined company expected to trade under the ticker symbol "AGLT" on a major North American exchange. Agility chose the SPAC route to efficiently access public capital for fulfilling existing customer orders, expanding commercial dep |
| QREDQuasarEdge Acquisition | Robseek Intelligence Inc. | AI/Tech | $1.0B | Jun 9, 2026 | $10.04 | +0.2% | Definitive (DA signed) | 6868 | Robseek Intelligence Inc. is a Cayman Islands exempted company that operates as an AI-driven technology firm building what it calls a "device + data + AI + service" ecosystem — a layered platform designed to transform smart-device distribution into a physical-world AI entry network. At the base of its architecture sits a terminal layer comprising screens, kiosks, phones, robotics, and sensors that serve as programmable interfaces between people and commercial spaces. Above that, an edge-and-data layer handles on-device compute and privacy-first data collection, which feeds an AI engine responsible for generative content, optimization, targeting, and full-funnel measurement. The top layer encompasses applications and monetization, anchored by NOVA AI, the company's advertising platform that turns existing screens into intelligent, measurable inventory through generative content, campaign distribution, real-time A/B testing, and analytics on real-world surfaces. Robseek also plans to launch ALIF AI, a broader smart-device ecosystem encompassing smartphones and other connected devices. The company describes its commercial flywheel as a compounding loop — "device network → data acquisition → AI optimization → continuous monetization" — where every new terminal adds distribution, every interaction enriches the data asset, and every model update raises yield across the entire installed base. Bloomberg characterizes Robseek as a software development company that develops advertising platforms and an integrated ecosystem combining devices, data, artificial intelligence, and services, serving customers worldwide. The company's initial market focus is the Middle East, with ambitions to expand across multiple regions. Robseek identifies four defensible moats: end-to-end system integration spanning hardware, software, AI, and commercial operations with no third-party dependencies in the critical path; local landing capability through on-ground teams handling compliance, partnerships, installation, and service at market speed; supply chain depth leveraging direct China-based manufacturing, logistics, and sourcing for cost and customization advantages; and a data-AI loop where every deployed terminal feeds the optimization engine. The platform is device-agnostic, with each new terminal class — whether AI compute nodes, edge screens, USB dock nodes, or service robotics — inheriting the AI, data, and commercial layers above it. Meng Tang serves as a director and has acted as the company's chief executive officer and shareholder representative. The company's principal shareholder is Robseek Limited, a British Virgin Islands business company. Financial details disclosed in the merger materials are notably thin: no revenue, losses, margins, founding year, headquarters, employee count, or customer base were clearly provided in the sources reviewed, meaning investors are being asked to underwrite a forward-looking growth narrative rather than a fully disclosed financial track record. On June 9, 2026, Robseek entered into a definitive Agreement and Plan of Merger with QuasarEdge Acquisition Corporation (NYSE: QRED), a Cayman Islands SPAC, in a stock transaction valuing Robseek at approximately $1 billion pre-money equity. The deal structure calls for Robseek shareholders to receive 100,000,000 ordinary shares of the Purchaser entity valued at $10.00 per share. QuasarEdge will merge into the Purchaser subsidiary, which becomes the publicly listed company, while a merger sub will merge into Robseek, leaving Robseek as a wholly owned subsidiary. The transaction has been approved by both boards and is subject to shareholder approvals, SEC effectiveness of a registration statement, stock exchange listing approval, and other customary closing conditions. The parties executed shareholder and sponsor support agreements to secure votes and prevent redemptions, with the sponsor Aspira Capital Consulting committing not to redeem and to vote in favor. Lock-umore ▾less ▴ |
| SSACSPACSphere Acquisition | Mobilewalla | AI/Tech | $250M | May 29, 2026 | H2 2026 | $10.09 | +0.5% | Definitive (DA signed) | 7070 | at trust — free optionality setup |
| LCCCLakeshore IIINo date ahead | CPRO Electronics | AI/Tech | $185M | May 22, 2026 | Q4 2026 | $10.53 | -4.7% | Definitive (DA signed) | 6060 | CPRO Electronics Co., Ltd. is a Seoul-based physical AI security company founded on September 24, 1996 by Young-Soo Lee, who continues to serve as Chairman and Chief Executive Officer. Originally established as a manufacturer of CCTV cameras and broadcasting apparatus, CPRO has spent roughly three decades in the video security industry, building its own brand SECUBEST and expanding into intelligent video analytics and AI-driven retail data solutions. The company maintains offices in Seoul, Hanoi, and Calibania, with manufacturing facilities in Korea and Vietnam and an R&D center in Korea focused on special cameras such as high-resolution multi-sensor, small PTZ, and Bubble Free Dome models. With approximately 47 employees and annual revenue of around $23.6 million (down 9.6% year-over-year, with an operating loss of $1.25 million), CPRO is classified as a medium-sized enterprise in South Korea's Gyeonggi-do province. The company holds 17 patent documents across four patent families, covering innovations in CCTV camera design, PTZ bubble structures, dome-type camera mounting, and network-accessible surveillance systems. CPRO's product portfolio spans AI cameras, network and analog security cameras, intelligent video analysis systems, and its RetailTrend service platform, which provides people counting, flow maps, zone traffic analysis, and gender/age estimation for retail customers. The company's Edge AI cameras analyze customer preferences and movement patterns, linking detected data to the cloud to sell data-driven solutions to large retail chains aimed at improving operational efficiency, customer convenience, and accident prevention. CPRO also emphasizes its commitment to supporting collaboration between robots and humans by providing data on tasks, behavioral ranges, and material movement. Its technology meets National Defense Authorization Act (NDAA) and Trade Agreement Act (TAA) criteria, and the company has been recognized as a Global Top Security 50 company for 2025. CPRO serves diverse industries including banking, gaming, education, healthcare, residential, traffic management, and retail, deploying its systems worldwide. On May 22, 2026, CPRO Electronics Holding Limited entered into a definitive business combination agreement with Lakeshore Acquisition III Corp. (Nasdaq: LCCC), a special purpose acquisition company, in a deal that implies a pro-forma enterprise value of approximately $326 million assuming no redemptions from the trust account. Under the terms of the all-stock merger, CPRO shareholders will receive ordinary shares of the combined company valued at $185 million (payable at $10.00 per share), reduced dollar-for-dollar for any target group debt exceeding $26 million. The transaction was approved by both boards of directors and is expected to close in the fourth quarter of 2026, subject to shareholder approvals, regulatory clearances, and effectiveness of a Form F-4 registration statement. The combined entity will operate under the name "CPRO Holding Limited" and trade on a U.S. national securities exchange. The deal includes voting and support agreements from Lakeshore's sponsor and key CPRO holders, along with lock-up provisions ranging from 180 days to 12 months and amended registration rights to facilitate post-merger liquidity. CPRO is pursuing the SPAC route to access U.S. public capital markets and fund what founder Young-Soo Lee described as an "aggressive growth plan" in the face of global AI competition. The company views the listing as a strategic vehicle to accelerate its development across the United States, Asia, and other international markets, leveraging its position in the rapidly growing AI camera segment. Lakeshore's CEO Bill Chen cited CPRO's business model and its standing in the AI camera market as key attractions, noting the "vast potential for the Company's growth in this very important market segment." The transaction is supported by legal advisors Loeb & Loeb LLP (Lakeshore) a |
| ATIIArchimedes Tech II | Forge Nano, Inc. | AI/Tech | $1.2B | Apr 20, 2026 | $10.65 | -0.3% | Definitive (DA signed) | 7575 | Forge Nano, Inc. is a Denver-based advanced materials and semiconductor equipment company built on proprietary Atomic Layer Deposition (ALD) nanocoating technology, branded as Atomic Armor™. The company's platform applies ultra-thin, conformal coatings at the atomic level to improve the performance and durability of materials across two core verticals: lithium-ion batteries for defense applications and semiconductor manufacturing equipment for AI-era chips. Forge Nano traces its roots to research at the University of Colorado Boulder, where ALD NanoSolutions—an earlier spinout founded in 2001 by CU Boulder faculty including Alan Weimer and Steven George—merged with Forge Nano in 2020 to consolidate atomic-level manufacturing expertise. The company has spent fourteen years in technology development and over a decade in commercial sales, amassing a portfolio of more than 200 patents. Its ALD tools reportedly operate at nearly ten times industry-average throughput speeds and roughly one hundred times precursor efficiency, enabling applications in advanced semiconductor packaging, through-silicon vias, photonics, memory, logic, and heterogeneous integration. Forge Nano manufactures both its nanocoating equipment and lithium-ion battery cells in the United States using a predominantly domestic supply chain, and its technology has already been deployed in Spire Global satellites launched via SpaceX. The company is led by Co-Founder and Chief Executive Officer Paul Lichty, who has guided Forge Nano through multiple funding rounds and a bootstrapped period of seven to eight years following its founding. Strategic equity investors include a roster of Tier-1 industry players: Volkswagen, Air Liquide, Hanwha Aerospace, GM Ventures, and LG Technology Ventures. The company has also secured significant U.S. government backing, including a $100 million Department of Energy grant to support its battery manufacturing facility. Forge Nano recently closed its Series D round with $82.2 million funded and committed, with additional PIPE financing including a $23 million tranche at $10.00 per share and participation from Samsung SDI, which also formed a landmark strategic partnership to enable U.S. production of advanced battery cells—a relationship Forge Nano compares to the Tesla–Panasonic model. The company holds $84 million in binding off-take agreements and a pipeline of letters of intent exceeding $2 billion, targeting an estimated $359 billion-plus total addressable market by 2034 across lithium-ion batteries and semiconductor ALD equipment. Forge Nano's customers and products span critical industries including energy, defense, high-performance manufacturing, photonics, and data centers. Its TEPHRA semiconductor wafer fabrication platform has been selected by leading photonics and Fortune Global 500 communications companies for commercial integrated photonics manufacturing, and the company has secured equipment orders for 200mm wafer fabs while planning a 300mm ALD platform build-out. On the battery side, Forge Nano is developing lithium-ion battery cells for the U.S. Department of Defense and is constructing a gigawatt-hour-capacity manufacturing facility in Morrisville, North Carolina, with an expected 18-month timeline from groundbreaking to early commissioning. The company is also expanding into pharmaceuticals, data centers, and quantum computing. A 2028 legislative mandate prohibiting U.S. defense procurement of foreign-made battery cells is expected to further catalyze Forge Nano's defense market opportunities, and the company has been identifying secure supply chain government needs for over a decade. Forge Nano is going public via SPAC to accelerate the next phase of its growth, providing capital and market visibility to scale U.S. manufacturing of semiconductor tools and lithium-ion batteries. The business combination with Archimedes Tech SPAC Partners II Co. (NASDAQ: ATII) values Forge Nano at approximately $1.2 billion pre-mon |
| IBACIB Acquisition | GNQ Insilico, Inc. | AI/Tech | $500M | Mar 16, 2026 | Sep 24, 2026 · 14d | $10.92 | +1.1% | Definitive (DA signed) | 7171 | GNQ Insilico, Inc. is a TechBio company incorporated under the federal laws of Canada and headquartered in Toronto, with operations also described as California-based. Founded by Rehan Huda, who serves as the company's Founder, Chairperson, and Chief Executive Officer, GNQ Insilico is focused on transforming and de-risking drug development through the convergence of artificial intelligence, quantum computing, genomics, and systems biology. The company's mission is to revolutionize pharmaceutical R&D and healthcare delivery by enabling precision medicine at scale, leveraging digital twin technology, advanced biological modeling, and quantum-enhanced AI platforms to help pharmaceutical companies discover, develop, and optimize therapeutics more efficiently. By addressing critical inefficiencies across the healthcare value chain, GNQ aims to accelerate development timelines, reduce costs, and deliver improved patient outcomes across multiple disease areas. The company operates three proprietary AI-powered platforms: a Drug Assessment platform, which launched in the fourth quarter of 2025, and Drug Simulation and Digital Twins platforms, both expected to roll out later in 2026. These platforms are designed to serve pharmaceutical companies, investors, and healthcare providers worldwide, enabling smarter investment decisions and accelerating drug development toward truly personalized medicine. GNQ's integration of genomics, artificial intelligence, and quantum computing represents a differentiated approach to addressing the significant challenges facing drug discovery and development, positioning the company to capture meaningful market share in the precision medicine space. GNQ Insilico is going public through a definitive business combination agreement with IB Acquisition Corp. (Nasdaq: IBAC), a Nevada-based special purpose acquisition company, in a transaction structured as a statutory plan of arrangement under the Canada Business Corporations Act. The deal values GNQ at approximately US$500 million (about C$688 million), with additional consideration possible through revenue and share-price earnout provisions. The transaction is expected to provide approximately US$15 million in proceeds to GNQ, comprising a PIPE of up to US$10 million, cash held in IBAC's trust account, and up to US$2 million in bridge financing through convertible notes and warrants. The merger is expected to close in the third quarter of 2026, subject to customary closing conditions including shareholder approvals and Ontario Superior Court approval. The SPAC route provides GNQ with the resources and public market visibility needed to expand its commercial partnerships and scale its solutions globally. Following the close, GNQ's current executive team will continue to lead the combined company, with a five-member board of directors consisting of four GNQ designees and one independent IBAC sponsor designee. IBAC's CEO and Chairman Al Lopez emphasized that GNQ's differentiated approach to drug discovery and development made it an compelling partner at the forefront of innovation, expressing confidence in the talented GNQ team's ability to execute on its vision of making precision medicine accessible and economically viable for patients worldwide. Legal counsel for the transaction includes Cassels Brock & Blackwell LLP and Barnes & Thornburg LLP for GNQ, and Dentons Canada LLP and ArentFox Schiff LLP for IBAC, with I-Bankers Securities acting as financial and capital markets advisor. |
| RFAIRF Acquisition IINo date ahead | Nanyang Biologics | AI/Tech | $1.5B | Oct 2, 2025 | $32.01 | -188.9% | Definitive (DA signed) | 45Premium risk45Premium risk | Nanyang Biologics (NYB) is a Singapore-based, AI-driven drug discovery and biotechnology company operating at the intersection of biodiversity and artificial intelligence. Founded in 2020 as a university spin-out from Nanyang Technological University Singapore (NTU), NYB has spent roughly five years developing a joint laboratory with NTU focused on tropical medicinal plants and their therapeutic potential. The company's flagship Vecura AI platform is powered by its proprietary Drug-Target Interaction Graph Neural Network (DTIGN), a structure-and-outcome-guided discovery model that applies graph neural networks and protein language models to predict how natural compounds interact with disease targets. In 2024, the DTIGN engine outperformed competitors by 27% in benchmarking tests published in IEEE, and it won first prize among over 700 startups at the SuperAI Genesis Startup Competition 2025 in Singapore. NYB is building what it believes will be one of the world's largest AI-curated natural compound libraries, already comprising over 50,000 unique organisms and their chemical compounds, and it has entered a memorandum of understanding with NVIDIA, Hewlett Packard Enterprise, and Equinix to provide scalable computing and sovereign digital infrastructure for large-scale molecular screening. The company's therapeutic pipeline consists of five preclinical molecules derived from tropical medicinal plants, targeting high-unmet needs in oncology, cardiovascular health, and mental health. Its lead candidate, NB-A002, is a first-in-class DNA Damage Response (DDR) therapy targeting the previously undruggable ILF2 protein, inducing synthetic lethality in DDR and Homologous Recombination Deficiency cancers, including BRCA-mutated and BRCAness tumors. NYB positions NB-A002 as a potential superior alternative to PARP inhibitors for ovarian, breast, lung, and other solid tumors, addressing a market projected to reach $19.5 billion by the mid-2030s. Additional pipeline assets include NB-B101 for solid tumors, NB-C201 for cardiovascular health, and NB-C301 for mental health conditions, all progressing through preclinical stages with growing patent protection. The company also offers a consumer nutraceutical product line alongside its pharmaceutical pipeline. NYB is led by Chairman Dr. Roland Ong, a serial entrepreneur, and Lead Principal Investigator Professor Li Hoi Yeung, who co-founded the joint laboratory initiative between NTU and NYB. The company's key investors include The9 Limited (Nasdaq: NCTY), which provided its first funding in 2020, Mercatus Capital (a Singapore-based family office), and the Ignition AI Accelerator. According to PitchBook, NYB has approximately 16 employees and has progressed through accelerator and clinical trial stages. The company has been recognized by U.S. News & World Report 2025, which ranked Singapore second worldwide for AI, and NYB has established strategic collaborations with major technology partners to build enterprise-grade infrastructure for healthcare innovation. On October 2, 2025, NYB entered into a definitive business combination agreement with RF Acquisition Corp II (Nasdaq: RFAI), a Singapore-based SPAC targeting deep technology in Asia, in a transaction valuing NYB at approximately $1.5 billion pre-money equity value. The merger is expected to close in the first or second quarter of 2026, subject to shareholder approval, with the combined company to list on Nasdaq under the ticker symbol "NYB." Existing shareholders, including The9 and Mercatus Capital, will roll over 100% of their equity and retain majority ownership and board control. NYB is pursuing the SPAC route to accelerate its AI-driven drug discovery efforts, with Chairman Ong stating that public listing will break through barriers that have long hindered medical advancement, significantly reduce R&D time and costs, and open new opportunities for therapeutic development. The SPAC's CEO, Tse Meng Ng, praised NYB for building a diffe [verified via Google + 425: Nanyang Biologics AI drug discovery, $1.5B] |